A detailed history of Group One Trading, L.P. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 476 shares of EWTX stock, worth $13,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
476
Holding current value
$13,104
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$26.63 - $36.62 $12,675 - $17,431
476 New
476 $12,000
Q2 2023

Aug 09, 2023

BUY
$5.71 - $10.29 $571 - $1,029
100 New
100 $0

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.74B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.